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INTRODUCTION 
 
In heterochronic parabiosis, a young and old animal are 
surgically connected to share a common blood 
circulation.  Experiments in mice showed this shared 
circulatory milieu restored tissue health and 
regeneration of the old partner; and at the same time, 
the young partner experienced a regenerative decline in 
a number of tissues [1-5].  In parabiosis, both organs 
and blood are shared, but further work focusing on 
exchanging only blood or infusing only plasma further 
detailed age-related effects on different tissues [6, 7].  
However, parabiosis is not clinically translatable and 
infusion of young blood or plasma into old mammals is 
controversial  and  fraught  with  multiple side-effects  
 
 
[1, 3, 6-10]. Blood fractionation is typically cumber-
some, and it is inherently complicated by the fact that 
the rejuvenative activities are likely to be contained in 
multiple molecularly different fractions [11].  Plus, the 
assays for determining such activity are themselves 
complex, thus adding to the hurdles of a screen for 
active blood molecules. With these observations to 
consider, what would be the key set of molecular 
parameters that were changed by the blood 
heterochronicity and what would be best translational 
way forward?  
 
The changes that manifest with aging include altered 
cell metabolism, increased Reactive Oxygen Species 
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ABSTRACT 
 
We hypothesize that altered intensities of a few morphogenic pathways account for most/all the phenotypes of 
aging.  Investigating this has revealed a novel approach to rejuvenate multiple mammalian tissues by defined 
pharmacology.  Specifically, we pursued the simultaneous youthful in vivo calibration of two determinants: 
TGF-beta which activates ALK5/pSmad 2,3 and goes up with age, and oxytocin (OT) which activates MAPK and 
diminishes with age.   The dose of Alk5 inhibitor (Alk5i) was reduced by 10-fold and the duration of treatment 
was shortened (to minimize overt skewing of cell-signaling pathways), yet the positive outcomes were 
broadened, as compared with our previous studies.  Alk5i plus OT quickly and robustly enhanced neurogenesis, 
reduced neuro-inflammation, improved cognitive performance, and rejuvenated livers and muscle in old mice. 
Interestingly, the combination also diminished the numbers of cells that express the CDK inhibitor and marker 
of senescence p16 in vivo. Summarily, simultaneously re-normalizing two pathways that change with age in 
opposite ways (up vs. down) synergistically reverses multiple symptoms of aging.  
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(ROS), inflammation, senescence, and decline in 
immune function. However, from the viewpoint of 
tissue maintenance and regeneration, we postulated that 
these arise from changes in tissue growth and 
homeostasis and specifically in key signaling networks 
regulating stem cells and their differentiated niches. In 
support of this idea, pathway modifier-based 
approaches for the enhancement of aged tissue repair 
and maintenance have been reported, for example, by 
systemic delivery of OT which induces MAPK/pERK 
signaling [12], by forced activation of Notch-1 [13], by 
antagonism of TGF-beta/pSmad signaling [14], or by 
antagonism of the Jak/Stat pathway [15]. 
 
The highest risk from modulating key cell-fate 
regulatory signaling pathways come from changing 
levels too far above or too far below normal healthy 
levels. Such drastic alterations result in severe multi-
tissue side-effects. But high levels of a single modifier 
might be required to overcome the many age-specific 
molecular changes. For example, ectopic oxytocin (OT) 
might be needed at a considerably high dose to 
overcome age-elevated TGF-beta 1. And, the Alk5 
inhibitor of the TGF-beta receptor might be needed at 
high dose to overcome the lack of OT and other 
hormones with age.  
 
Using a two-prong approach of simultaneously 
diminishing TGF-beta signaling and adding OT (which 
activates pERK via the oxytocin receptor (OTR) [12]), 
we were able to reduce the required dose of Alk5i, 
shorten the duration of treatment and to achieve a more 
broad rejuvenation of the three germ-layer derivative 
tissues: brain, liver and muscle. And, we found that 
Alk5i+OT down-regulated the number of cells that 
show an age-associated increase of the cyclin dependent 
kinase (CDK) inhibitor and marker of senescence, p16, 
thereby representing a pharmacological combination of 
two FDA approved drugs to normalize this checkpoint 
protein, which when chronically elevated negatively 
impacts tissue health [16-22].  
 
The translational ramifications of this study are in the 
attenuation and reversal of multi-tissue attrition and 
decline of cognitive performance in old mammals, 
leading to novel defined pharmacology for a number of 
degenerative and metabolic age-associated diseases, as a 
class.  
 
RESULTS 
 
In vivo delivery of Alk5i and OT 
 
To look for synergy between Alk5i and OT, we first 
tested a dose curve of these compounds individually and 
in combination, in vitro on muscle stem/progenitor 
cells. Cells were freshly derived from regenerating 
C57.B6 mouse muscle, and cultured in old mouse serum 
overnight, culture conditions in which the proliferative 
capacity is typically low [12, 23]. Alk5i and OT 
combined at some lower concentrations were sufficient 
for enhancing proliferation of these old muscle cells 
cultured with old serum, versus using each molecule 
alone (Figure 1A). This result is consistent with the 
OT/OTR and Alk5/TGF-beta/pSmad pathways inter-
acting through pERK [2, 11, 24].  To confirm this 
possible mechanism, we studied the effects of Alk5i, 
OT and Alk5i+OT on the levels of oxytocin receptor 
(OTR). Interestingly, the combination of Alk5i+OT 
increased the expression of OTR above either drug 
alone or control (Figure 1B).  And of note, OT and OTR 
signaling is needed for healthy muscle, bone, brain and 
metabolism [2, 12]. 
 
Considering these data, we designed the in vivo study 
depicted in Figure 1C.  We selected a combination of 
1/10 the previously published [14] dose of Alk5i (0.02 
nmol/g-day), and OT dosed at 1 µg/g-day by 
subcutaneous administration into mice to provide 
systemic in vivo delivery of these molecules. C57.B6 
male mice at 22-24 months of age (old) were injected 
subcutaneously and daily with Alk5i+OT or HBSS 
vehicle control for seven consecutive days. As a 
positive control for tissue health and regeneration, 
C57.B6 male mice at 2-3 months of age (young) were 
injected subcutaneously with vehicle control, HBSS.  
After two days of Alk5i+OT or HBSS injections, some 
mice from each cohort underwent experimental 
cardiotoxin-induced injury to their muscle (Tibialis 
Anterior and Gastrocnemius) and were again injected 
daily with Alk5i+OT or HBSS for the 5 days of 
recovery (e.g., 7 days total treatment); while other mice 
were analyzed in the absence of tissue injury. A number 
of assays were performed on tissues that represent each 
of the three developmental germ layers, and animal 
cognitive capacity was evaluated, as described below.   
 
We first tested the in vivo effects of Alk5i+OT on the 
regeneration of skeletal muscle, which we previously 
showed to be rejuvenated by either drug alone, albeit, at a 
10-fold higher concentration of Alk5i [14], or upon a 
longer dosing with OT [12]. Tibialis anterior (TA) and 
gastrocnemius (Gastroc) muscle of the young and old 
mice were injured by cardiotoxin (CTX), and at 5 days 
post injury the success in muscle regeneration was deter-
mined, based on the numbers of newly-formed muscle 
fibers and the degree of fibrosis, as in [6, 14]. The 
Alk5i+OT combination improved the regeneration and 
reduced fibrosis of the old injured muscle; and notably, 
this phenotype manifested at a much lower dose of Alk5i 
than previously published [14] and after just seven daily 
injections of the Alk5i+OT mix (Figure 1D, E).   
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Figure 1. Effects of OT and Alk5i on myogenic proliferation, OTR expression and muscle repair in vivo. (A) Old muscle stem 
cells were freshly isolated from aged (23-24mo old) C57.B6 male mice and cultured in Opti-MEM with 5% old mouse serum. The indicated 
doses of Alk5i and OT (both micromolar) were added to 103cells per well of 96 well plates for 24 hours. Cells were pulsed with BrdU, 
immunostained and counted. Shown is the percent proliferation visualized as a heat map. The effects of OT and Alk5i on proliferation are 
dose dependent and at some doses Alk5i+OT has a more robust effect than each molecule alone. (B) Old (23-24mo) C57.B6 mice were 
administered by subcutaneous injections with oxytocin (OOT), Alk5i (OA5i), a mixture of OT and Alk5i (OA5iOT) or HBSS (Oc) in vivo for 7 
days, daily. Young (2-3mo) mice (Yc) were injected with HBSS in an identical manner. The expression levels of oxytocin receptor (OTR) 
were assayed by real-time qRT-PCR in the TA muscles of these mice and were normalized to Actin. OA5iOT as compared to Oc (*p = 
0.030). N = 8 for Yc, N = 7 for Oc, N = 5 for OOT, N = 5 for OA5i, and N = 5 for OA5iOT. (C) Schematic of the experimental procedure. Old 
(23-24 month) C57.B6 mice were injected subcutaneously with Alk5i+OT (0.02 nmol/g/day for Alk5i, and 1 µg/g/day for OT) (OA5iOT) or 
control vehicle (HBSS) (Oc) for 7 days daily. The young C57.B6 mice (Yc, 3-4 month), were identically administered with HBSS for 7 days. 
After two days of Alk5i+OT or HBSS injections, some young and old mice underwent experimental muscle injury and were then treated 
with Alk5i+OT or HBSS for 5 days; while other mice were analyzed in the absence of tissue injury. Male mice were used in these studies. 
(D)  TA muscles were injured by injections of CTX and 5 days later, muscles were snap-frozen in OCT and cryosectioned to 10 µm. H&E 
staining was performed where newly formed muscle fibers are smaller and with central nuclei. These nascent myofibers form efficiently 
in the young, but not old injured muscles. As shown in representative H&E panels, Alk5i+OT dramatically enhanced in vivo myogenesis (dense 
areas of new myofibers) and diminished fibrosis (white areas devoid of muscle fibers). Scale bar=50 µm. (E) The regenerative index and 
fibrotic indices were defined at 5 days post CTX injury, as in (Rebo J., et al 2016); Alk5i+OT improved muscle regeneration and reduced 
fibrosis (*p=0.02201, **p Oc & OA5iOT = 0.0029, **p Yc & OA5iOT = 0.00870). N=5 for each cohort in both regenerative and fibrotic studies.  
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Hippocampal neurogenesis is improved, and neuro-
inflammation is diminished in old mice that are 
treated with Alk5i+OT 
 
Neurogenesis in the hippocampus decreases drama-
tically with age [25]. In previous work, heterochronic 
parabiosis or dosing with high level of Alk5i were 
shown to enhance hippocampal neurogenesis of old 
mice, while heterochronic blood exchange had no 
positive effects on old neurogenesis and profoundly 
attenuated young neurogenesis [2, 6, 7, 14]. The effects 
of ectopic OT have not been explicitly studied with 
respect to age-specific neurogenesis.  
 
To determine whether Alk5i+OT is capable of 
enhancing neurogenesis in the old mice after a short 7-
day treatment, we analyzed 25 micron serial brain 
sections for the numbers of proliferating (Ki67+) neural 
stem cells in the subgranular zone (SGZ) of the Dentate 
Gyrus (DG) of hippocampus, as published [2, 6, 14, 26].  
HBSS-injected young and old mice were used as 
positive and negative controls, respectively. The neural 
stem cell identity of the SGZ Ki67+ cells was 
confirmed by Sox-2 co-staining; both Sox-2 and Ki67 
displayed the expected nuclear immunofluorescence, 
while the background of the isotype-matched IgG 
controls was minimal (Figure 2A). As shown in Figure 
2B and quantified in 2D, Alk5i+OT when provided 
systemically in vivo, resulted in a ~ 2-fold increase in 
hippocampal neurogenesis of old animals in just one 
week.  Young control mice had approximately 10-fold 
better SGZ neurogenesis than old controls, which is 
consistent with the body of published work [2, 6, 14, 
27].  
 
One negative causal factor in the old brain that 
contributes to neurogenic and neuroprotective decline is 
an age-related increase in microglia and central 
inflammation locally in brain, as well as an influx of 
peripheral leukocytes to the brain [28, 29]. To assess 
these phenotypes in our study, we quantified the 
numbers of CD68+ monocytic cells that were robustly 
detected in the thalamus region (Figure 2) of the brains 
of each studied cohort. As shown in Figure 2C, 
quantified in Figure 2E, roughly 8-fold more CD68+ 
cells were present in the old control brains as compared 
to young. Importantly, a 7-day treatment with 
Alk5i+OT reduced the numbers of CD68+ cells by 
~50% in the brains of old mice, with high statistical 
significance. 
 
These results establish that the low dose of Alk5i 
combined with OT quickly and robustly enhances SGZ 
neurogenesis) and reduces brain inflammation. 
Cognitive ability is improved in the old mice treated 
with Alk5i+OT 
 
Cognitive decline accompanies aging in mice and 
humans, causing diminished ability to learn, memorize 
and eventually, leading to the loss of quality of life and 
independence. With age, neurogenesis decreases in the 
hippocampus – the region responsible for learning and 
memory, and neuro-inflammation increases, and each 
has been suggested as factors that contribute to the age-
imposed cognitive decline [30–32]. 
 
Since hippocampal neurogenesis improved and neuro-
inflammation diminished after Alk5i+OT treatment, we 
went on to explore whether treatment with these 
compounds would enhance the cognitive abilities of 
aged mice.  First, we tested sensory processing using a 
whisker-dependent texture discrimination task (Figure 
3A; [33, 34].  In contrast to young mice (< 2 months 
old), aged mice failed to distinguish between novel and 
familiar textures (Figure 3B, C).  Such failure may be 
due to inability to distinguish textural differences per 
se, or due to defective short-term memory, i.e., failure 
to remember whether a texture has been previously 
encountered.  To assess short-term memory, we sub-
jected aged mice to the novel object recognition (NOR) 
test [35], with the resting period matching that of the 
texture discrimination task (5 min, Supplementary 
Figure 1A).  We found that aged mice spent significant-
ly more time interacting with the novel object, just as 
young mice did (Supplementary Figure 1B).  Thus, 
impaired tactile sensitivity or processing, rather than 
defective short-term memory, is likely the culprit.  
Next, we examined whether aged mice could retain 
memory by extending the waiting period in the NOR 
test to 2h (Figure 3D).  Aged mice only approached the 
novel object at chance level, suggesting defective 
memory retention (Figure 3E, F).  Henceforth we set the 
resting period in the NOR test to 2h.  
 
We then treated the same group of aged mice with 
Alk5i+OT for 7 to 8 days and re-tested them on the 
texture discrimination and the NOR test.  We found that 
the treatment did not alter the overall amount of 
interaction with textures and objects during the 
encoding phase of each task (Figure 3 B, E).  
Remarkably however during the test phase, the 
treatment significantly improved the performance of 
each old animal in both tasks: demonstrating 
preferential interest to novel texture and novel object 
(Figure 3 C, F).   
 
Collectively, these data show that 2-year-old mice 
(equivalent to 75 to 80-year-old humans) become more 
competent in cognitive tasks after a week of daily 
administration of Alk5i+OT. The rapid cognitive 
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improvement in old mice that were administered with 
A5i+OT is more likely to be associated with the 
diminished neuro-inflammation rather than increased  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
neurogenesis, as it is expected take a much longer than 
a week for newly formed neurons to differentiate and 
integrate into the brain circuitry. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Alk5i+OT treatment improves hippocampal neurogenesis and attenuates inflammation in the brains of old 
mice. (A) Immunofluorescence was performed on serial 25-micron brain sections with anti-Ki67 (proliferation marker) and anti-Sox-2 
(neural stem cell marker), using Hoechst to stain all nuclei.  A representative image of ki67 (red)/Sox2 (green)/Hoechst (blue) triple 
positive cells in the hippocampal Dentate Gyrus of a young control animal treated with HBSS for 7 consecutive days is shown. Scale 
bar=50 µm. Isotype-matched IgG negative controls exhibited minimal background fluorescence. (B) Immunofluorescence was 
performed on serial 25-micron brain sections with anti-Ki67 (proliferation marker), using Hoechst to stain all nuclei, imaging the cells 
in the SGZ of the hippocampal Dentate Gyrus. Representative images of Ki67 (red)//Hoechst (blue) positive cells in the hippocampal 
Dentate Gyrus. Arrows point to these double-positive cells. Scale bar=50 µm. (C) Immunofluorescence was performed on serial 25-
micron brain sections with anti-CD68 (monocyte/microglia marker), using Hoechst to stain all nuclei. Representative images of CD68 
(red)/Hoechst (blue) double positive cells. Scale bar=50 µm. (D) The numbers of Ki67+/Hoechst+ cells in the SGZ of DG were 
quantified through entire hippocampi of each cohort and were found to decline with age as expected, and to increase in the Alk5i+OT 
old cohort, as compared to the control vehicle-treated old cohort.  Young control (Yc n=5), old control (Oc n=5), Alk5i+OT (OA5iOT 
n=6) *p Oc & OA5iOT = 0.043, **p Yc & OA5iOT = 0.00159, mean and SE are shown.  (E) The number of CD68+ brain cells were 
quantified in all cohorts and were found to increase with age and to decline in Alk5i+OT-treated old muscle, as compared to the 
vehicle-treated old control. N young control (Yc n=5), old control (Oc n=5), Alk5i+OT (OA5iOT n=6). ***p<0.001, **p=0.0226.  
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Alk5i+OT reduces liver adiposity, and liver fibrosis 
 
To examine whether Alk5i+OT is effective in liver in 
addition to the muscle and brain, similarly to what we 
found after heterochronic parabiosis and blood 
exchange, the above described mice that were 
administered for 7 days with Alk5i+OT or HBSS, were 
also studied for liver fibrosis and liver adiposity. As 
others and we previously published, in mice with age 
liver fibrosis and adiposity become markedly increased, 
and these liver health parameters are improved in old 
mice by decreasing or diluting the old systemic milieu 
and/or replacing it with young [6, 23, 36].  
 
To evaluate the liver health, we performed immuno-
fluorescence for albumin on 10-micron liver sections 
and quantified the relative number of albumin-negative 
fibrotic clusters.  Additionally, liver adiposity was 
measured by Oil Red O staining in these tissue sections, 
as in [6, 23].  As shown in Figure 4, the low dose of 
Alk5i combined with OT within one-week reduced the 
adiposity and fibrosis  of old  livers,  making  these  more  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
similar to control young mice. Additionally, muscle 
injury increased liver adiposity in the old mice (Figure 
4).  
 
These results demonstrate that defined pharmacology of 
Alk5i+OT exhibits positive effects not just on brain or 
skeletal muscle, but also on liver health in old mice; and 
to a similar extent as reported for heterochronic 
parabiosis and blood exchange. 
 
Alk5i+OT attenuates the numbers of p16+ cells in 
multiple tissues of old mice in vivo  
 
 Considering the enhanced myogenesis and 
neurogenesis that we observed in the old mice, which 
were administered with Alk5i+OT, we decided to have 
a closer look at the effects of this two-molecule 
pharmacology on the CDK inhibitor and marker of 
senescence, p16. An increase in p16-expressing cells is 
thought to be deleterious, particularly in old age [19, 37, 
38], and knocking out p16 enhances adult stem cell 
performance in multiple tissues [18, 20, 21]. The levels 
Figure 3. Alk5i+OT treatment improves cognitive performance in aged mice. (A) Schematics of the whisker-dependent texture 
discrimination task.  (B, C) Alk5i+OT treatment does not affect the explorative behavior of aged mice during the encoding phase (B, 
p=0.659), but significantly improves the performance in texture discrimination (C, p<0.001).  (D) Schematics of the NOR test.  (E, F) 
Alk5i+OT treatment does not affect the explorative behavior of aged mice during the encoding phase (E, p=0.864), but significantly 
enhances their preference to the novel object during the testing phase (C, p<0.001). n = 7 for both tasks.  Light grey: individual animal. 
Black: group average.  Error bars: S.E.M. p<0.001. 
 
 
www.aging-us.com 5634 AGING 
of p16 and other CDK inhibitors, p15, p21 and p27, 
increase with age in muscle stem cells, interfering with 
productive regeneration [39-41].  OT has been shown to 
down-modulate the CDKI p21 in a pERK-dependent 
manner [12], but the effects on p16 were not studied. 
Similarly, at a high dose, Alk5i attenuates p21 levels in 
brain of old mice [14], but p16 was not studied.  
 
We examined the effects of in vivo administered 
Alk5i+OT on the number of p16+ cells in brain, muscle,  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
and liver by p16-specific immunofluorescence on tissue 
sections. The p16 signal was nuclear as expected, and 
immunofluorescence from isotype-matched IgG 
controls was negligible (Figure 5). As shown in 
representative images, p16+ mono-nucleated cells were 
observed in the polymorphic region of the hippocampus 
near the Dentate Gyrus (Figure 5A), and the numbers of 
these p16 expressing cells were elevated in old mice as 
compared to young, and reduced in old animals that 
were administered with Alk5i+OT, as compared to the  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Liver adiposity and fibrosis are reduced in old mice treated with Alk5i+OT.  Livers were collected from non-
injured mice and at 5 days post cardiotoxin-induced muscle injury, as illustrated in Figure 1C. (A) 10 µm liver sections were 
immunostained with Albumin+ (green), using Hoechst dye (blue) to label all nuclei, representative image is shown.  (B) Albumin-
negative fibrotic clusters (commonly found in old, but not young livers) were quantified; the incidence of fibrosis is reduced in the 
livers of old injured  mice that were administered with Alk5i+OT, as compared to HBSS control **p=0.001, N for old control (Oc)=3, 
N for old+Alk5i+OT (OA5iOT)=3. (C) Isotype-matched IgG signal for albumin immunodetection was minimal. (D) Representative Oil 
Red O staining of liver sections show an age-specific increase in adiposity and reduction of old liver adiposity by the Alk5i+OT in 
both injured and uninjured animals. (E) Image J quantification of red pixel density in the Oil Red O assay was performed, as 
published (Rebo et al, 2016). Alk5i+OT diminished the liver adiposity of the old injured mice.  N=6 in each injured cohort, ****p= 
0.002 Oc & OA5iOT, N=6 in each uninjured cohort **p<0.001 Oc & OA5iOT. All scale bars=50 µm. 
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Figure 5. p16 levels are decreased in situ in muscle and brain by Alk5i+OT. Cryosections of injured and uninjured muscle (10 µm, 
each) and brain (25 µm) were assayed for the number of p16+ nuclei by immunofluorescence, using Hoechst to label all nuclei. p16 showed 
the predicted nuclear localization in these assays. (A) Representative images of p16+ cells in the polymorphic layer near the dentate gyrus in 
an old control brain and isotype-matched IgG non-specific immunofluorescence are shown. Arrows point to p16+ (red)/Hoechst+ (blue) 
nuclei in the stated region. (B) The number of p16+ cells in the polymorphic layer of the hippocampus was decreased by the Alk5i+OT 
treatment, ***old control & Alk5i+OT p=0.0003, scale bar=50 µm at 40x magnification, IgG scale bar=50 µm at 20x magnification. Young 
control (Yc) n=5, old control (Oc) n=8, Alk5i+OT (OA5iOT) n=8. (C)  Representative images of p16+ nuclei outside of the injury site in the TA 
muscle of an old vehicle control mouse at 5 days post single CTX injection and isotype-matched IgG non-specific immunofluorescence, are 
shown; scale bar=50 µm at 20x magnification. (D) The number of p16+/Hoechst+ nuclei divided by the total number of nuclei (Hoechst+) per 
field-of-view at 20x magnification (frequency of p16+ nuclei) was quantified. The frequency of p16+ nuclei outside of injury sites is 
significantly greater in muscle of old vehicle-treated control mice, as compared to young control and old Alk5i+OT treated. N=5 for each 
cohort. Young control (Yc), old+Alk5i+OT (OA5iOT), old control (Oc) N.S. = P-value Yc &OA5iOT = 0.064, *** = P-value Yc & Oc = 0.011, **** = 
P-value OA5iOT & Oc = 0.000064. (E) Representative images of the sites of injury/regeneration of young and old TA muscle from control - 
HBSS treated mice; 10-micron sections desmin (green), p16 (red) immunofluorescence and isotype-matched IgG control non-specific 
immune-fluorescence are shown. Scale bar is 50 micron at 40x magnification. Robust p16+ nuclei are observed in both young and old muscle, 
and many of these are in centrally-nucleated newly formed desminhigh myofibers.  The frequency of p16+ centrally-nucleated myofibers was 
quantified (right).  The relative number of these p16+ fibers were found to be nearly identical in young injured (n=5) and old injured (n=7) muscle.  
N.S. = P-value Old and Young = 0.7918.   
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vehicle-treated old mice (Figures 5B).  As compared to 
young muscle, higher number of p16+ mono-nucleated 
cells were also found in old TA muscle, outside of the 
injury sites; and the numbers of these p16+ cells 
declined in old mice that were administered with 
Alk5i+OT (Figure 5C and D).  
 
Interestingly, during these studies we have detected 
significant numbers of p16+ cells in both young and old 
muscle at the injury/regeneration sites, at 5 days post 
injury, a time point when proliferating myoblasts 
typically differentiate into new myofibers (Figure 5 E). 
Indeed, the p16 immunofluorescence was found in a 
majority of newly-formed centrally-nucleated desmin-
high myofibers in young and old tissue and there was no 
statistically-significant age-specific difference in the 
numbers of newly-formed p16+ muscle fibers (Figure 
5E). Co-immunodetection of p16 and laminin was also 
performed to confirm the findings with p16 and desmin 
(Supplementary Figure 2).  We did not detect p16+ cells 
in the livers of either young or old mice by the same 
immunofluorescence assay. 
 
These data show that cells which express p16 become 
elevated with age, as expected from the body of 
published work, [19, 37, 38, 42], and suggest that the 
seven-day Alk5i+OT treatment reduces the numbers of 
p16+ cells in brain and in muscle of old mice. These 
data also demonstrate that p16+ myofibers are a normal 
part of physiological regeneration of injured muscle in 
both young and old. 
 
DISCUSSION 
 
This work demonstrates a reversal in multiple tissues, of 
several signs of aging, through the simultaneous 
modulation of two signaling pathways, one of which 
becomes elevated with age and the other reduced. 
Translationally, this study points toward a pharma-
cological approach to rapidly enhance the health and 
maintenance of multiple old tissues. Here we focused 
on a few key age-related parameters of the three germ 
layer tissues: neurogenesis and neuroinflammation of 
the brain, regeneration and fibrosis of the skeletal 
muscle and adiposity and fibrosis of the liver. In future 
work if would be interesting to study how these 
seemingly unrelated aging features become rapidly 
rejuvenated by A5i+OT, and if additional phenotypes, 
such as muscle innervation, neural plasticity, 
metabolism, etc. also become improved in old animals. 
The observed rejuvenating effects are at least as robust 
as, and act faster than, heterochronic parabiosis [2, 23]. 
Additionally, the effects of Alk5i+OT are more positive 
for neurogenesis and restore the functional behavior of 
old mice, as compared with heterochronic blood 
exchange [6].  
OT and various Alk5 inhibitors [43] are already FDA 
approved for applications that are different from age-
related degenerative pathologies, and hence reposition-
ing this combination is facilitated. OT is not associated 
with cancers or any other pathologies, and in fact a lack 
of OT is known to cause depression, obesity, osteo-
porosis and muscle wasting [12, 44–46]. Alk5 inhibitors 
are in clinical trials for combating cancer progression, 
because at high levels TGF-beta switches from 
inhibiting to promoting cancer metastasis, and from 
attenuating to promoting inflammation [14, 47, 48].  Of 
note, both Alk5i and OT have been shown to cross the 
blood brain barrier, enabling delivery to all organs and 
tissues [14, 49]. 
 
The effects of Alk5i+OT on neurogenesis and 
myogenesis implicate simultaneous and rapid positive 
changes to the tissue specific stem / progenitor cells and 
their niches.  The reduction of fibrosis in muscle and 
liver represents another global feature of organ aging 
that is reversed by the Alk5i+OT. The observed 
reduction in liver adiposity might be indicative of 
general metabolic improvements in the old mammals. 
There is a good consensus on the dramatic age-related 
decline in muscle stem cell proliferation after tissue 
injury or attrition. Approaches that enhance satellite cell 
proliferation improve not just myogenesis, but also 
tissue health and strength of old animals without any 
cell transplantation [1,12].  Aged stem cells have more 
than adequate regenerative potential, and enhancement 
of their proliferation leads to positive outcomes [1, 12, 
14]. This notion is expanded in current work. 
 
Central neuro-inflammation, with its characteristic 
swollen microglia expressing CD68, is not only causal 
to the age-related loss of neurons [50], but also 
implicated in psychiatric diseases such as schizophrenia 
[51]. In this regard, the observed attenuation of CD68+ 
brain cells by Alk5i+OT might also be clinically 
relevant on several fronts.  
 
It is likely that the rapid cognitive improvement in aged 
mice results from reduced neuro-inflammation, rather 
than from the increased neurogenesis. First of all, there 
was no time in our study for newly-formed neuronal 
cells to mature and integrate into the brain networks, as 
we assayed cognitive performance after just 7 days of 
Alk5i+OT administration.  Secondly, prior studies have 
suggested that neuro-inflammation induced by heat 
stress severely impairs the performance on New Object 
Recognition tests (the cognitive skill that were 
examined in our work), and the administration of 
minocycline, an anti-inflammatory agent, inhibits heat 
stress-induced cognitive deficits and astrogliosis [52].  
Attenuated neuro-inflammation might reflect a direct 
effect of our pharmacology on these myeloid lineage 
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cells, an indirect effect through diminished peripheral 
and/or central inflammation, or both. At high dosage, 
Alk5i alone reduces the levels of the inflammatory 
marker B2M [14], but the low dose of Alk5i that is 
combined with OT increases the levels of OTR in old 
animals, and OTR signaling is needed for the health of 
the brain, as well as, peripheral tissues. Thus, a low 
dose of Alk5i that is combined with OT has greater 
potential clinical advantages.  
 
Other considerations for not overly diminishing TGF-
beta signaling include the need for this pathway in the 
balance between tissue damage and host defense [53], 
immune modulation through attenuation of MHC genes 
and concomitant activation of NK cells [54, 55], and 
regulation of proliferation, differentiation, and growth 
of various cell types [20]. These reasons and our 
experimental observations in sum support the notion of 
minimizing the dose of pathway modulating drugs such 
as Alk5i, which as shown here, does not restrict but 
broadens the positive multi-tissue effects through 
combination with OT.  OT alone has been shown to 
enhance the regeneration of old injured muscle in a 9-
day protocol [12]. However, we shortened the treatment 
to 7 days and expanded the positive outcomes to brain 
and liver, by combining OT with Alk5i. 
 
One mechanism which might be involved in the 
rejuvenative effects of Alk5i+OT, is the reduction of 
numbers of p16+ cells in old tissues. High p16 generally 
corresponds with senescent cell phenotypes, and there is 
a profound interest in development of new pharma-
ceuticals for p16high cell ablation (senolytics) or p16 
down-modulation (senomorphics) as a way to increase 
life-span and/or health-span [16, 38, 42, 56-59].    
  
Alk5i+OT is needed at a much lower dose and for much 
shorter time than another molecule, ABT263, a Bcl-2 
inhibitor that has senolytic properties (and relatively 
higher toxicity) [16]. Recently, a synthetic peptide 
named FOXO4-DRI was shown to interfere with 
canonical FOXO4-p53 interaction, consequently 
inducing apoptosis in senescent cells [60]. Though 
promising, this peptide is not FDA approved and its 
toxicity effects, acute or chronic, are not known. 
Further in contrast to our present findings, its positive 
effects on neurogenesis, muscle, and liver were not 
reported.  
 
Importantly, our work suggests that p16 elevation at the 
time and place of de-novo myofiber formation might 
represent a required physiologic response (similar to a 
previous report on skin wound healing, [61]. Indeed, 
when normalized by the total de-novo centrally-
nucleated myofibers,  the numbers of those with p16high  
myonuclei that regenerated tissue injury were nearly 
identical between the young and old mice.  Thus, 
ablation of all p16-positive cells could be a risky 
therapy; in contrast, a moderate, youthful re-
normalization should be safer.  
 
In summary, the new paradigm of this work is that 
individual detriments of aging might have a common 
cause: the concordant alteration of a few signal trans-
duction networks, and points to a rational strategy of 
re-calibrating a few key pathways for combatting 
many age-related diseases simultaneously, as a class. 
 
MATERIALS AND METHODS 
 
Animal experiments 
 
Animals 
All procedures were performed in accordance with the 
administrative panel of the Office of Laboratory Animal 
Care, and the protocol was approved Animal Care and 
Use Committee. Young male C57BL/6 mice were 
purchased from the Jackson Laboratory (#00664). Old 
male C57BL/6 mice (20-24 month) were purchased 
from the National Institute on Aging. 
 
Mice were housed at UC Berkeley and maintained on 
2018 Teklad Global 18% Protein Rodent Diet: Crude 
Protein 18.6%; Fat (ether extract); 6.2%; Crude 
Fiber 3.5%; Energy Density 3.1 kcal/g 13.0 kJ/g. 
Calories from Protein   24%, Calories from Fat 18% 
Calories from Carbohydrate 58%. 
 
Oxytocin (OT) 
Was purchased from Bachem (H-2510) and a 30mM 
stock prepared in sterile water.  
 
Alk5 inhibitor (A5i) 
TGF-β1 Type I Receptor Kinase Alk5 inhibitor 2-(3-(6-
Methylpyridin-2-yl)- 407 1H-pyrazol-4-yl)-1,5-
naphthyridine, was purchased from Enzo Life Sciences, 
and a 25 mM concentrated stock dissolved in DMSO. 
OT and/or A5i or control vehicle (HBSS) was injected 
subcutaneously to old male C57.B6 mice (23-24 
month), daily for 7 days before sacrifice. 3 month 
C57.B6 male mice identically injected with HBSS were 
used as young controls. 
 
Cardiotoxin muscle injury 
Two days after the start of oxytocin and/or Alk5 
inhibitor or control, mice were injured by intramuscular 
injections of cardiotoxin (Sigma, 10 µl per muscle at 0.1 
µg/ml) into the tibialis anterior (TA). Five days after the 
injury, TA muscles were isolated.  
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Cultures of muscle satellite cells 
Myofiber-associated satellite cells were isolated from 
TA and Gastrocnemius muscles of aged (22-24mo old) 
C57.B6 male mice and plated at 103 cells per well of 96 
well plates in Opti-MEM with 5% old mouse serum.  
Alk5i and OT were serially diluted to the cell wells 
ranging from 0-1.5 and 0-15 micromolar, respectively, 
and cells were cultured for an additional 24 hours. Cells 
were pulsed with BrdU for 4 hours, immunostained and 
counted.  
 
Primary and secondary antibodies 
 Were used at 0.5-1 µg/ml as follows:  
-Albumin: R&D Systems, Mouse, MAB1455, 1:1000 
-Beta-actin: Thermo Scientific MA5-15739   
-BrdU: Abcam  ab6326 (BU1/75) 
-CD45: Rat, Clone F10-89-4, EMD Millipore 05-1410, 
1:500 
-Desmin: Sigma-Aldrich, Mouse, DE-U-10, 1:300 
-Laminin: Santa Cruz Biotechnology, Rat, sc-59854, 
1:200 
-Ki67: Abcam, Rabbit, ab16667, 1:200  
-p16: Abcam, Rabbit, 189034 
-Sox2: Santa Cruz Biotechnologies sc-17320, 1:400  
-Isotype-matched mouse, rat and rabbit IgG’s were used 
as negative controls (Sigma Aldrich), 1 μg/ml 
-Goat anti-rabbit Alexa 546: Invitrogen A11010, 
1:2,000  
-Goat anti-mouse Alexa 488: Invitrogen A11029, 
1:2,000  
-Donkey anti-rat Alexa 488: Invitrogen A21208, 
1:2,000 
-DNA was stained by Hoechst DNA dye at 1 μg/ml: -
Hoechst 33342 from Sigma Aldrich (B2261) 
 
Behavioral tests 
The whisker-dependent texture discrimination test was 
performed as previously described [34], with the 
encoding, resting, and testing phase lasting 10, 5, and 5 
min, respectively.  The novel object recognition (NOR) 
test was performed as previously described [34 ,35] 
with the encoding and the testing phases both set to 10 
min.  Such modifications of encoding and testing 
duration are intended to accommodate the slow 
movement of aged mice.  Two resting periods (5 min and 
2 h) were used for the NOR test in two separate sessions 
on the same mouse.  Behavioral analyses were performed 
with the analyst blinded to the identity and the conditions 
(age, resting period, pre/post-treatment) of the mice.  
 
Tissue isolation 
Was performed postmortem. Brains from uninjured 
animals were harvested and incubated in 4% para-
formaldehyde (PFA) overnight at 40C and subsequently 
stored in 30% sucrose. Brain, liver, and muscle 
harvested from injured animals and muscle and liver 
from uninjured animals were snap-frozen in isopentane 
(-700C) and embedded in Tissue-Tek Optimal Cutting 
Temperature (OCT, Sakura Finetek, The Netherlands).  
 
Tissue sectioning, and immunofluorescence 
Tissue sectioning, and immunofluorescence of brain, 
muscle, and liver sections were directly collected on 
positively charged frosted glass slides. Brain, liver, and 
muscle sections were 25 μm, 10 μm, and 10 μm 
respectively. Tissues were fixed with 70% ETOH 
overnight (muscle and liver) or 4% PFA for 10 minutes 
(brain) and blocked with 1% bovine growth serum 
(BGS, Hyclone), in 1X PBS for 30 minutes at room 
temperature. They were subsequently permeabilized 
with 0.1% Triton-X 100 for 10-15 min on ice, incubated 
with primary antibodies at 40C overnight in 
PBS+1%BGS, washed in this buffer and incubated with 
secondary fluorochrome tagged antibodies and Hoechst 
for 2 hours at RT. IgG controls with isotype-matched 
antibodies were routinely done and non-specific 
fluorescence was minimal. 
 
Hemtoxylin and eosin staining 
Was performed on tibialis anterior muscle sections that 
were 10 micron thick. This assay was performed as 
previously described [6].   
 
Oil red staining 
10-micron liver sections were hydrated in 1X PBS for 
approximately 10 minutes. The sections were then 
washed in 60% isopropanol for 5 minutes and later 
placed in isopropanol-based Oil Red O staining solution 
for 15 minutes. After, the sections were washed in 60% 
isopropanol once more for 5 minutes. Nuclei on these 
sections were stained by a 1-minute wash in 
hematoxylin. The sections were finally washed in 
deionized water for one minute. Fluoromount was used 
as the mounting medium and images were taken from 
these slides.  
 
qRT-PCR analysis 
Tissue lysates from frozen muscle embedded in OCT 
were prepared by collecting 12 slices of 50 µm thick 
sections. Tissues were homogenized and total RNA was 
extracted with RNeasy Mini Kit (QIAGEN) according 
to manufacturer’s instructions. Reverse transcription 
was performed with Superscript III First-Strand 
Synthesis System (Invitrogen). Real-time PCR was 
performed using iQ™ SYBR Green Supermix (Bio-
Rad) under CFX Connect Real-Time System (Bio-Rad) 
and reactions were run in triplicates. 200 ng of total 
cDNA were used for the initial amplification using 
specific primers to each gene of interest. Amplification 
was performed with a denaturation step at 95°C for 3 
minutes, followed by 50 cycles of denaturation at 95°C 
for 10 seconds and primer extension at 60°C for 30s. 
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Melt curves were analyzed and samples with peaks 
indicating improper products were eliminated. House-
keeping gene actin was used as an internal control to 
normalize the variability in expression levels, and 
results were analyzed via Gene Study with CFX 
Manager Software. One outlier was eliminated because 
it fell further from the mean than 1.5 times the 
interquartile range (in the Oc cohort).   
 
Primers 
-actin-f: CGCCACCAGTTCGCCATGGA  
-actin-r: TACAGCCCGGGGAGCATCGT  
-OXTR-f: GATGTCGCTCGACCGCTG  
-OXTR-r: CGGTACAATGTAGACGGCGA  
 
Data quantification 
 
At least five independently treated animals per each 
cohort (young control, old control, old + Alk5i, old 
+OT, old + Alk5i+OT) were used in quantification for 
each tissue; and such assays (qRT PCR, 
immunofluorescence, functional performance test) were 
performed in 3-4 replicates. Student two-tail t-test 
and/or ANOVA were performed for analyzing the data 
quantification, and p-values of 0.05 or less were 
considered statistically significant. 
 
The animal’s performance in the NOR test and the 
whisker-dependent texture discrimination task was 
quantified by calculating a discrimination index as 
previously described [34]. Muscle regeneration indices 
were calculated by counting percent de-novo myofibers 
with central nuclei to total nuclei in multiple images of 
10-micron muscle sections for independently treated 
animals.  
 
Muscle fibrosis was quantified by measuring fibrotic 
areas on Image J. These fibrotic areas were normalized 
to the area of the image taken at 20X (~ 14000 
micron^2).  
 
Hippocampal neurogenesis (Ki67+), p16+ SGZ cell 
numbers and CD68+ cell numbers were quantified by 
counting the number of respective cells (from multiple 
25-35-micron IF brain sections). The number of cells 
positive for Ki67, p16, or CD68 were extrapolated to the 
total thickness of the regions where they were identified 
(~2.8 mm for dentate gyrus and ~2.2 mm for thalamus).  
 
Counting cell numbers from multiple 10-micron 
sections for each cohort produced the quantification of 
albumin+, and Hoechst+ cells (hepatocytes) and of 
albumin- fibrotic cells per area in images obtained at 
20X. Oil Red O quantification was done in 10-micron 
liver sections, by obtaining the total area of the red fatty 
droplets as a percentage of the entire 20X image area, 
using a consistent color-threshold function in software 
ImageJ.  
 
The number of p16+ nuclei in brains and in injured and 
uninjured muscle was divided by the total number of 
nuclei present in their respective field of views; for 
injured muscle, it was divided by the number of 
myonuclei in desmin+ myofibers, at 20X magnification. 
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SUPPLEMENTARY FIGURES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 1. Varying resting period results in different performance of NOR test in aged mice. (A) Schematics of 
the NOR test, two resting time periods were tested.  (B, C) Aged mice perform similarly to young mice under 5 min rest (B, 
p=0.455), but fail to recognize the novel object following 2 h rest (C, p<0.001).  Light grey: individual data points. Black: group 
average.  Error bars: S.E.M.  *** p<0.001.                      
 
 
 
 
 
 
 
 
www.aging-us.com 5645 AGING 
 
 
 
Supplementary Figure 2. Representative images of p16/laminin immunofluorescence at young and old muscle injury sites 5 
days post injury. Laminin+ (green) nascent myofibers of young and old muscle concomitantly expressing p16 (red) against 
Hoechst DNA dye (blue).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
